Hudson Bay Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.46M	Sell	62,330 -102,670	-62%	-$2.23M	0.01%	825
2025 Q4	$3.47M	Sell	165,000 -85,000	-34%	-$1.48M	0.01%	596
2025 Q3	$3.85M	Sell	250,000 -193,300	-44%	-$2.53M	0.01%	621
2025 Q2	$4.15M	Buy	443,300 +193,300	+77%	+$2.13M	0.01%	593
2025 Q1	$3.07M	Sell	250,000 -86,000	-26%	-$1.21M	0.01%	723
2024 Q4	$4.44M	Sell	336,000 -89,000	-21%	-$1.52M	0.02%	525
2024 Q3	$8.18M	Buy	+425,000	New	+$8.78M	0.03%	324
2023 Q4	–	Sell	-1,236,186	Closed	-$17.9M	–	876
2023 Q3	$17.9M	Buy	1,236,186 +761,186	+160%	+$14.4M	0.14%	98
2023 Q2	$9.94M	Buy	+475,000	New	+$9.89M	0.07%	178
2021 Q1	–	Sell	-160,000	Closed	-$3.56M	–	939
2020 Q4	$3.56M	Sell	160,000 -115,000	-42%	-$2.38M	0.04%	286
2020 Q3	$4.06M	Buy	275,000 +54,700	+25%	+$834K	0.06%	261
2020 Q2	$3.26M	Buy	+220,300	New	+$3.36M	0.06%	254